Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The correlation between pre-treatment CEA levels and the EGFR mutation status in advanced lung adenocarcinoma.

Journal of cancer research and therapeutics - 1 Apr 2024

Uysal Mukremin, Beypinar Ismail, Araz Murat

Abstract excerpt

BACKGROUND: The discovery of the epidermal growth factor receptor (EGFR) mutation, especially in adenocarcinoma, has led to a major change in the treatment of non-small-cell lung cancer (NSCLC). This study investigated the relationship between the EGFR mutation status and the carcinoembryonic antigen (CEA) levels at the time of diagnosis. MATERIALS AND METHODS: A total of 102 patients with EGFR mutation and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Carcinoembryonic Antigen

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Neoplasm Staging

Source

Identifiers

PMID: 38261436
DOI: 10.4103/jcrt.JCRT_1459_20

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The correlation between pre-treatment CEA levels and the EGFR mutation status in advanced lung adenocarcinoma.PMID 38261436Read ↗

Correlation between carcinoembryonic antigen (CEA) expression and EGFR mutations in non-small-cell lung cancer: a meta-analysis.Semantic proximity Read ↗

Correlation between EGFR mutations and serum tumor markers in lung adenocarcinoma patients.Semantic proximity Read ↗

Correlation between serum CEA levels and EGFR mutations in Chinese nonsmokers with lung adenocarcinoma.Semantic proximity Read ↗

Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations.Semantic proximity Read ↗

Associations between epidermal growth factor receptor gene mutation and serum tumor markers in advanced lung adenocarcinomas: a retrospective study.Semantic proximity Read ↗

Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned.Semantic proximity Read ↗

Association between serum CEA levels and ctDNA-detected Epidermal Growth Factor Receptor mutations in lung adenocarcinomaSemantic proximity Read ↗

[Epithelial growth factor receptor mutation status to the effective of survival in non-small cell lung cancer after surgery].Semantic proximity Read ↗

Clinical impact of pleural fluid carcinoembryonic antigen on therapeutic strategy and efficacy in lung adenocarcinoma patients with malignant pleural effusion.Semantic proximity Read ↗

Value of ¹⁸F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma.Semantic proximity Read ↗

Serum carcinoembryonic antigen levels predicts the efficacy of EGFR-TKI in non-small cell lung cancer harboring EGFR mutations.Semantic proximity Read ↗

Smoking habit and chemo-radiotherapy and/or surgery affect the sensitivity of EGFR plasma test in non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.